Sulfacetamide
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
| Common Name | Sulfacetamide(F05886) |
| 2D Structure | |
| FRCD ID | F05886 |
| CAS Number | 144-80-9 |
| PubChem CID | 5320 |
| Formula | C8H10N2O3S |
| IUPAC Name | N-(4-aminophenyl)sulfonylacetamide |
| InChI Key | SKIVFJLNDNKQPD-UHFFFAOYSA-N |
| InChI | InChI=1S/C8H10N2O3S/c1-6(11)10-14(12,13)8-4-2-7(9)3-5-8/h2-5H,9H2,1H3,(H,10,11) |
| Canonical SMILES | CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N |
| Isomeric SMILES | CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N |
| Synonyms |
N-((4-Aminophenyl)sulfonyl)acetamide
sulfacetamide
144-80-9
Sulphacetamide
Acetosulfamine
N-Acetylsulfanilamide
Acetosulfamin
Albucid
N-Sulfanilylacetamide
Sulfacetimide
|
| Classifies |
Predicted: Pesticide
|
| Update Date | Nov 13, 2018 17:07 |
Chemical Taxonomy
| Kingdom | Organic compounds |
| Superclass | Benzenoids |
| Class | Benzene and substituted derivatives |
| Subclass | Benzenesulfonamides |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Aminobenzenesulfonamides |
| Alternative Parents | |
| Molecular Framework | Aromatic homomonocyclic compounds |
| Substituents | Aminobenzenesulfonamide - Benzenesulfonyl group - Aniline or substituted anilines - Organic sulfonic acid or derivatives - Organosulfonic acid or derivatives - Sulfonyl - Acetamide - Aminosulfonyl compound - Amino acid or derivatives - Carboxylic acid derivative - Organic oxide - Organopnictogen compound - Primary amine - Organosulfur compound - Organooxygen compound - Organonitrogen compound - Amine - Carbonyl group - Organic oxygen compound - Organic nitrogen compound - Hydrocarbon derivative - Aromatic homomonocyclic compound |
| Description | This compound belongs to the class of organic compounds known as aminobenzenesulfonamides. These are organic compounds containing a benzenesulfonamide moiety with an amine group attached to the benzene ring. |
Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 214.239 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Complexity | 299 |
| Monoisotopic Mass | 214.041 |
| Exact Mass | 214.041 |
| XLogP | -1 |
| Formal Charge | 0 |
| Heavy Atom Count | 14 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
ADMET
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB+ | 0.9881 |
| Human Intestinal Absorption | HIA+ | 0.9912 |
| Caco-2 Permeability | Caco2- | 0.5396 |
| P-glycoprotein Substrate | Non-substrate | 0.8806 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9743 |
| Non-inhibitor | 0.9449 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9484 |
| Distribution | ||
| Subcellular localization | Mitochondria | 0.6595 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.6975 |
| CYP450 2D6 Substrate | Non-substrate | 0.9058 |
| CYP450 3A4 Substrate | Non-substrate | 0.7775 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9609 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9595 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9312 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9546 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9552 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8371 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9919 |
| Non-inhibitor | 0.9775 | |
| AMES Toxicity | Non AMES toxic | 0.9279 |
| Carcinogens | Non-carcinogens | 0.8623 |
| Fish Toxicity | High FHMT | 0.5295 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.5441 |
| Honey Bee Toxicity | Low HBT | 0.7759 |
| Biodegradation | Not ready biodegradable | 0.9686 |
| Acute Oral Toxicity | III | 0.8236 |
| Carcinogenicity (Three-class) | Non-required | 0.5176 |
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -1.2924 | LogS |
| Caco-2 Permeability | 0.9982 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 1.7849 | LD50, mol/kg |
| Fish Toxicity | 2.4207 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | -0.1173 | pIGC50, ug/L |
MRLs
| Food | Product Code | Country | MRLs | Application Date | Notes |
|---|---|---|---|---|---|
| Milk | Japan | 0.01ppm | |||
| Other Terrestrial Mammals,Edible Offal | Japan | 0.1ppm | |||
| Cattle,Edible Offal | Japan | 0.1ppm | |||
| Other Terrestrial Mammals,Kidney | Japan | 0.1ppm | |||
| Cattle,Kidney | Japan | 0.1ppm | |||
| Other Terrestrial Mammals,Liver | Japan | 0.1ppm | |||
| Cattle,Liver | Japan | 0.1ppm | |||
| Other Terrestrial Mammals,Fat | Japan | 0.1ppm | |||
| Cattle,Fat | Japan | 0.1ppm | |||
| Other Terrestrial Mammals,Muscle | Japan | 0.1ppm | |||
| Cattle,Muscle | Japan | 0.1ppm |
References
| Title | Journal | Date | Pubmed ID |
|---|---|---|---|
| Survey of Veterinary Drug Residues in Raw Milk in Hebei Province, China. | J Food Prot | 2017 Oct 17:1890-1896 | 29039709 |
| A Drug Combination Screen Identifies Drugs Active against Amoxicillin-InducedRound Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA DrugLibrary. | Front Microbiol | 2016 May 23 | 27242757 |
| Rapid determination of sulfonamide residues in pork by surface-modifiedhydrophilic electrospun nanofibrous membrane solid-phase extraction combined withultra-performance liquid chromatography. | Anal Bioanal Chem | 2016 Aug | 27235160 |
| Optimal conditions for determination of zinc bacitracin, polymyxin B,oxytetracycline and sulfacetamide in animal feed by micellar electrokineticcapillary chromatography. | Food Addit Contam Part A Chem Anal Control Expo Risk Assess | 2008Apr | 18348041 |
| Broad-specificity immunoassays for sulfonamide detection: immunochemical strategyfor generic antibodies and competitors. | Anal Chem | 2006 Mar 1 | 16503608 |
| Topical metronidazole combination therapy in the clinical management of rosacea. | J Drugs Dermatol | 2005 Jul-Aug | 16004021 |
| Molecular modeling of hapten structure and relevance to broad specificityimmunoassay of sulfonamide antibiotics. | Bioconjug Chem | 1999 Jul-Aug | 10411455 |
| Confirmatory method for sulfonamide residues in animal tissues by gaschromatography and pulsed positive ion-negative ion-chemical ionization massspectrometry. | J AOAC Int | 1993 Sep-Oct | 8241826 |